Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2003
12/24/2003WO2003105885A1 Novel method of screening
12/24/2003WO2003105877A1 Pharmaceutical compositions
12/24/2003WO2003105859A1 Powdery respiratory tonic composition
12/24/2003WO2003105857A1 Anti-inflammatory compositions and methods of use
12/24/2003WO2003105843A1 Methods of using isothiazole derivatives to treat cancer or inflammation
12/24/2003WO2003105838A2 Metabolite
12/24/2003WO2003105821A1 A pharmaceutical composition comprising a corticosteroid and a nonsterodial anti-inflammatory agent
12/24/2003WO2003105805A1 Composition for treatment of inflammatory disorders
12/24/2003WO2003105776A2 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE
12/24/2003WO2003105771A2 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
12/24/2003WO2003091232A3 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
12/24/2003WO2003090662A3 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
12/24/2003WO2003086396A9 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
12/24/2003WO2003082807A3 Amino acids with affinity for the alpha-2-delta-protein
12/24/2003WO2003082340B1 Injectable veterinary composition for small animals
12/24/2003WO2003075926A8 Use of proton pump inhibitors for the treatment of airway disorders
12/24/2003WO2003075015A3 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
12/24/2003WO2003072558A3 Arylsulfone derivatives
12/24/2003WO2003070914A3 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/24/2003WO2003068760A3 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
12/24/2003WO2003068224A3 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases
12/24/2003WO2003068166A3 Treatment of ophthalmic disorders using urea and urea derivatives
12/24/2003WO2003066806A3 Therapeutic use of aziridino compounds
12/24/2003WO2003064685A3 Genetic polymorphisms in the preprotachykinin gene
12/24/2003WO2003063800A3 8-heteroaryl xanthine adenosine a2b receptor antagonists
12/24/2003WO2003062236A8 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES
12/24/2003WO2003061653A9 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases
12/24/2003WO2003053361A3 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE
12/24/2003WO2003050251A3 Hematopoietic cells from human embryonic stem cells
12/24/2003WO2003045416A3 Antiphlogistic agent and the use thereof
12/24/2003WO2003040174A3 Substituted amino ketone compounds
12/24/2003WO2003038095A3 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents
12/24/2003WO2003037886A3 Heteroaromatic carboxamide derivatives for the treatment of inflammation
12/24/2003WO2003006491A3 Peptide-based compounds for targeting intergin receptors
12/24/2003WO2002074955A3 Oligonucleotides for regulating the gene coding for tnf$g(a) and/or genes controlled thereby and use thereof
12/24/2003WO2002058692A3 Halogenated composition, method for preparing same and uses thereof
12/24/2003WO2002046147A3 Perturbed membrane-binding compounds
12/24/2003WO2002034204A8 Calcilytic compounds
12/24/2003WO2002018540A3 Pyridine derivatives useful as cd40:cd154 binding interruptor compounds and use thereof to treat immunological complications
12/24/2003CN1462754A Medicinal complex dibaicalin zinc and its preparation method
12/24/2003CN1462618A Fibrauretine in dosage form of decentralization tablet
12/24/2003CN1131865C 作为选择性COX－2抑制剂的取代的咪唑并[1,2a]吖嗪 Substituted imidazole as selective COX-2 inhibitors and [1,2a] azines
12/24/2003CN1131855C 1－取代－1－氨基甲基－环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途 L-amino-1-substituted methyl - naphthenic derivative (= gabapentin analogs), their preparation and their use in the treatment of neuropathy
12/24/2003CA2489648A1 Chemical process
12/24/2003CA2489466A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
12/24/2003CA2489447A1 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same
12/24/2003CA2489367A1 Compounds, compositions, and methods
12/24/2003CA2489355A1 Methods of using isothiazole derivatives to treat cancer or inflammation
12/24/2003CA2489312A1 Modulation of activation of glucocorticoid receptors .beta.-breakdown products of glucocorticoids
12/24/2003CA2489293A1 O-sulphated bacterial polysaccharides and their use
12/24/2003CA2489286A1 2-naphtamide derivatives
12/24/2003CA2489249A1 Carboxamides derivatives
12/24/2003CA2489245A1 Fluorinated cycloalkyl-derivatized benzoylguanidines and their use as a medicament
12/24/2003CA2488708A1 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
12/24/2003CA2488643A1 Coated particles, methods of making and using
12/24/2003CA2488606A1 2,5-disubstituted 3-mercaptopentanoic acid
12/24/2003CA2488117A1 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
12/24/2003CA2488026A1 Powdery respiratory tonic composition
12/24/2003CA2487948A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators
12/24/2003CA2486215A1 Mitotic kinesin inhibitors
12/24/2003CA2485346A1 Human adam-10 inhibitors
12/23/2003US6667334 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
12/23/2003US6667331 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/23/2003US6667325 P38MAP kinase inhibiters; tumor necrosis factor alpha, interleukin 1 and 6 and cyclooxygenase II related diseases
12/23/2003US6667318 LFA-1 antagonist compounds
12/23/2003US6667316 Pharmaceutically active isoindoline derivatives
12/23/2003US6667314 Tropane derivatives useful in therapy
12/23/2003US6667300 Purinyl substituted quinazoline-4-one derivatives
12/23/2003CA2233178C (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
12/23/2003CA2149207C Compounds that inhibit t cell proliferation and methods using the same
12/18/2003WO2003104807A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
12/18/2003WO2003104485A2 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
12/18/2003WO2003104473A2 Galactosyl isomalt, method for production and use thereof
12/18/2003WO2003104459A1 Fcyriia transgenic animal model for autoimmune disease
12/18/2003WO2003104407A2 T cell receptor cdr3 sequences and methods for detection
12/18/2003WO2003104260A2 Pharmaceutical formulation
12/18/2003WO2003104254A2 Novel derivatives of androstane and androstene with ascorbic a cid and use thereof in treating or preventing various conditions, diseases, and disorders
12/18/2003WO2003104253A2 9-alpha-substituted estratrienes as selectively active estrogen
12/18/2003WO2003104250A1 New compounds for modulating the activity of exchange proteins directly activated by camp (epacs)
12/18/2003WO2003104236A1 Calcitonin gene related peptide receptor antagonists
12/18/2003WO2003104231A1 NOVEL INTERLEUKIN-1beta CONVERTING ENZYME INHIBITORS
12/18/2003WO2003104230A1 Bicyclic pyrimidine derivatives
12/18/2003WO2003104229A1 Novel fused imidazole derivative
12/18/2003WO2003104226A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
12/18/2003WO2003104225A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
12/18/2003WO2003104223A1 Pyrazole-derivatives as p38 kinase inhibitors
12/18/2003WO2003104222A1 Bisindolyl-maleimid derivatives as kinase inhibitors
12/18/2003WO2003104219A1 Nf-kb inhibitors
12/18/2003WO2003104218A1 Nf-:b inhibitors
12/18/2003WO2003104205A1 Aryloximes
12/18/2003WO2003104204A1 Pyridazine derivatives
12/18/2003WO2003104203A1 Therapeutic molecules and methods-1
12/18/2003WO2003104197A1 Polymorphic form xvi of fexofenadine hydrochloride
12/18/2003WO2003104195A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans
12/18/2003WO2003104178A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
12/18/2003WO2003103822A2 Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s)
12/18/2003WO2003103772A1 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the teatment of eye diseases such as glaucoma
12/18/2003WO2003103691A1 Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions
12/18/2003WO2003103687A1 Liquid formulation of decitabine and use of the same
12/18/2003WO2003103677A1 Derivatives of azepine and thiazeran as interleukin converting enzyme inhibitors
1 ... 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 ... 1272